Fibro Adipose Vascular Anomaly (FAVA) Research and Innovation

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Vascular Anomalies Center

At Boston Children's Hospital, we’re known for our science-driven approach. In fact, we’re home to the world's most extensive pediatric hospital research enterprise; and we partner with elite health care and biotech organizations around the globe.

Researchers and clinicians in our Vascular Anomalies Center (VAC) conduct research that may lead to the development of new, more effective therapies and perhaps, ultimately, ways to prevent FAVA and other anomalies. Members of our team published the first paper that defined FAVA as a unique vascular anomaly, and recently identified mutations in a gene called PIK3CA in tissues from several patients with FAVA. Also, in a recent retrospective review study, VAC clinicians determined that image-guided percutaneous cryoablation (a procedure where a clinician partially freezes a FAVA lesion) is an effective and safe option for controlling pain associated with FAVA.

The VAC has generated an extensive database on vascular anomalies, including FAVA. As our database grows, it will help shine more light on the causes, treatments, and long-term outcomes of FAVA and other vascular anomalies.

Fibro-adipose vascular anomalies: Reviewed by Ahmad Alomari, MD.
© Boston Children's Hospital, 2015

Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337